Kewaunee Scientific hits record $282M revenue and outlines fiscal 2027 growth investments
Executive summary: Kewaunee Scientific announced record revenue of $282 million and unveiled its fiscal 2027 growth investment plan. The result underscores robust demand in the laboratory equipment sector and indicates the company’s intent to expand capacity, which could influence supplier dynamics and investor sentiment.
Who is involved: Kewaunee Scientific (company), its shareholders, and the broader lab equipment market.
Likely next: The firm will detail the capex plan in its upcoming Q4 2026 earnings call and begin executing growth investments through fiscal 2027.
Kewaunee Scientific reported record revenue of $282 million, marking a strong performance in its latest reporting period. The company also disclosed plans for fiscal 2027 growth investments, signalling confidence in continued demand for its laboratory equipment and scientific instrumentation. This combination of solid earnings and forward-looking capital allocation suggests the firm is positioning for expansion amid a recovering market for lab supplies.
Timeline
- — Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments (Yahoo Finance)
Analysis — what this means
Likely next events
- Fiscal 2027 capex plan to be detailed in Q4 2026 earnings call (expected early November 2026)
- Potential expansion of manufacturing capacity slated for completion by Q2 2027
Sectors affected
- Laboratory equipment
- Scientific instrumentation
Historical parallels
- Thermo Fisher Scientific surpassed $40B in annual revenue in 2021, reflecting a similar growth trajectory in the lab equipment space